On June 29, WellCell rose 8.22% in regular trading, trading at 0.385 HKD/share, with turnover of approximately 67.5 million HKD.

On the news front, the company announced board personnel changes on June 26. Hu Hongyu was appointed as independent non-executive director and remuneration committee chairperson, while board chairman Qian Fenglei was appointed as nomination committee chairman and investment committee member. The changes followed the resignation of non-executive director Lin Qihao and independent non-executive director Huang Zhiwen, both citing personal business commitments.

Additionally, 576 million shares previously sold by major shareholder WellCell Group were deposited into Beta International Securities on June 23, with a deposited market value of approximately 230 million HKD, representing 14.40% of issued shares. The sale was executed at 0.3445 HKD per share. This completion marks the conclusion of the disposal overhang that had weighed on shares since early June, when the stock fell over 9% on the initial announcement. The removal of selling pressure has facilitated short-term capital inflows and a price rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)